Skip to main content
. 2017 Sep 25;56(23):3135–3143. doi: 10.2169/internalmedicine.8677-16

Table 4.

Comparison of Clinical Backgrounds and Success Rate of Approach Route.

Success rate, % (n/N)
TE TG TDL TDS TJ
N=11 N=16 N=7 N=4 N=4 p value
Clinical backgrounds
Malignant/Benign 100.0 66.7 72.7 80.0 60.0 50.0 66.7 100.0 - 100.0
(8/8) (2/3) (8/11) (4/5) (3/5) (1/2) (2/3) (1/1) (0/0) (4/4)
Non altered/Altered 87.5 100.0 66.6 100.0 57.1 - 100.0 50.0 - 100.0
(7/8) (3/3) (6/9) (6/6) (4/7) (0/0) (2/2) (1/2) (0/0) (4/4)
Ampulla/Anastomosis 90.0 100.0 69.2 100.0 57.1 - 75.5 - 100.0 -
(9/10) (1/1) (9/13) (3/3) (4/7) (0/0) (3/4) (0/0) (4/4) (0/0)
Obstruction side EHBD/ IHBD 100.0 75.0 70.0 83.3 100.0 40.0 66.6 100.0 100.0 -
(7/7) (3/4) (7/10) (5/6) (2/2) (2/5) (2/3) (1/1) (4/4) (0/0)
Over all technical success rate 90.9(10/11) 75.0(12/16) 57.1(4/7) 75.0(3/4) 100.0(4/4) 0.377

Chi-square test.

TE: transesophageal route, TG: transgastric route, TDL: transduodenal route long position, TDS: transduodenal route short position, TJ: transjejunum route